MarketCap
Facebook
X
TelegramQuarterly report 2025-Q1
added 05-14-2026
Aurora Cannabis DSO Ratio 2011-2026 | ACB
Annual DSO Ratio Aurora Cannabis
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | - | 99.8 | 114 | 21.9 | - | - | - | - | - |
All numbers in CAD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 114 | 21.9 | 78.5 |
DSO Ratio of other stocks in the Drug manufacturers industry
| Issuer | DSO Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Endo International plc
ENDP
|
79.9 | - | - | $ 28.9 M |  Irlanda |
 |
Evoke Pharma
EVOK
|
55.1 | - | - | $ 36.6 M |  USA |
 |
HEXO Corp.
HEXO
|
71.3 | - | 2.45 % | $ 38.1 M |  Canada |
 |
AcelRx Pharmaceuticals
ACRX
|
86.6 | - | 7.5 % | $ 6.35 M | USA |
 |
DURECT Corporation
DRRX
|
96.2 | - | - | $ 50.1 M | USA |
 |
Adamis Pharmaceuticals Corporation
ADMP
|
71.7 | - | 0.86 % | $ 117 M | USA |
 |
Aerie Pharmaceuticals
AERI
|
117 | - | - | $ 754 M | USA |
 |
Cumberland Pharmaceuticals
CPIX
|
382 | $ 6.17 | 3.14 % | $ 91.7 M | USA |
 |
Agile Therapeutics
AGRX
|
63.1 | - | 10.11 % | $ 58.2 M | USA |
 |
Alimera Sciences
ALIM
|
122 | - | - | $ 142 M | USA |
 |
Cronos Group
CRON
|
61.7 | $ 2.84 | -0.04 % | $ 1.09 B | Canada |
 |
Athenex
ATNX
|
89.9 | - | -23.39 % | $ 1.76 M | USA |
 |
Harrow Health
HROW
|
87.8 | $ 34.76 | -1.79 % | $ 1.28 B | USA |
 |
Avadel Pharmaceuticals plc
AVDL
|
49.9 | - | - | $ 2.06 B |  France |
 |
Catalent
CTLT
|
80.1 | - | - | $ 11.5 B | USA |
 |
Eagle Pharmaceuticals
EGRX
|
65.5 | - | -39.89 % | $ 27.7 M | USA |
 |
Pacira BioSciences
PCRX
|
50.3 | $ 23.54 | -0.61 % | $ 1.09 B | USA |
 |
Bausch Health Companies
BHC
|
79.8 | $ 5.31 | -1.94 % | $ 1.97 B | Canada |
 |
Organogenesis Holdings
ORGO
|
106 | $ 2.56 | -2.48 % | $ 324 M | USA |
 |
Canopy Growth Corporation
CGC
|
62.7 | $ 1.09 | -2.54 % | $ 117 M | Canada |
 |
Sonoma Pharmaceuticals
SNOA
|
65.5 | $ 1.15 | 3.6 % | $ 1.43 M | USA |
 |
Jupiter Wellness
JUPW
|
51.9 | - | - | $ 33.6 M | USA |
 |
Tilray
TLRY
|
52.8 | $ 5.58 | -1.33 % | $ 3.45 B | Canada |
 |
Lannett Company
LCI
|
83.1 | - | 1.15 % | $ 7.11 M | USA |
 |
OrganiGram Holdings
OGI
|
93 | $ 1.16 | 1.63 % | $ 111 M | Canada |
 |
Evolus
EOLS
|
62.9 | $ 6.61 | 0.61 % | $ 426 M | USA |
 |
Emergent BioSolutions
EBS
|
58.6 | $ 9.32 | 1.47 % | $ 499 M | USA |
 |
Veru
VERU
|
91.5 | $ 2.33 | 0.43 % | $ 34.1 M | USA |
 |
Neoleukin Therapeutics
NLTX
|
3.46 | - | - | $ 193 M | Canada |
 |
cbdMD
YCBD
|
13.4 | $ 0.81 | -0.02 % | $ 3.26 M | USA |
 |
Assertio Holdings
ASRT
|
268 | $ 23.44 | -0.02 % | $ 150 M | USA |
 |
ProPhase Labs
PRPH
|
111 | - | - | $ 5.07 M | USA |
 |
Radius Health
RDUS
|
34.7 | - | - | $ 1.42 B | USA |
 |
PetIQ
PETQ
|
43.1 | - | 1.64 % | $ 400 M | USA |
 |
Recro Pharma
REPH
|
62.7 | - | -4.76 % | $ 65.3 M | USA |
 |
OptiNose
OPTN
|
138 | - | - | $ 1.08 B | USA |
 |
SCYNEXIS
SCYX
|
2.74 | $ 0.73 | -0.72 % | $ 36.5 M | USA |
 |
PLx Pharma
PLXP
|
14.1 | - | -27.8 % | $ 2.56 M | USA |
 |
Viatris
VTRS
|
67 | $ 16.19 | 0.48 % | $ 18.8 B | USA |
 |
Zomedica Corp.
ZOM
|
31 | - | -0.21 % | $ 98 M | USA |
 |
Zynerba Pharmaceuticals
ZYNE
|
14.6 K | - | - | $ 55.5 M | USA |
 |
Rockwell Medical
RMTI
|
43.3 | $ 0.75 | -1.47 % | $ 27 M | USA |
 |
China Pharma Holdings
CPHI
|
20.9 | $ 0.81 | 4.41 % | $ 3.48 M |  China |
 |
TherapeuticsMD
TXMD
|
2.3 K | $ 2.08 | -1.66 % | $ 24.1 M | USA |